RPG LIFE SCIENCES LTD. - 532983 - Corporate Action-Board approves Dividend
Recommended equity dividend of Rs. 9.60 per share of Rs. 8/- each (120%) for the financial year ended March 31, 2022, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting. RPG LIFE SCIENCES LTD. - 532983 - Audited Financial Results For The Quarter And Year Ended March 31, 2022
Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2022, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 29, 2022 along with Auditors Report thereon with unmodified opinion. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m. RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Outcome for Outcome Of The Board Meeting Held On April 29, 2022
Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m. RPG LIFE SCIENCES LTD. - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results Earnings Call for Audited Financial Results of the Company for the quarter and year ended March 31, 2022 will be held on Monday, May 2, 2022 at 4.00 p.m. IST. RPG LIFE SCIENCES LTD. - 532983 - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2022.
RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday, April 29, 2022, inter-alia, to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2022. Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2022 and will continue to remain closed till 48 hours after the results are made public on April 29, 2022. Kindly take this information on record. RPG LIFE SCIENCES LTD. - 532983 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayRPG LIFE SCIENCES LTD. 2CINL24232MH2007PLC169354 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rajesh Shirambekar Designation: Company Secretary & Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Vishal Shah Designation: Chief Financial Officer EmailId: [email protected] Date: 20/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. RPG LIFE SCIENCES LTD. - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate dated April 5, 2022 issued by Link Intime India Private Limited, Registrar and Transfer Agents, confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Compliance- Certificate Under Regulation 40(9)
We enclose herewith certificate issued by Practicing Company Secretary, pursuant to Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the financial year ended March 31, 2022. Kindly take the same on record. RPG LIFE SCIENCES LTD. - 532983 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Rajesh ShirambekarDesignation :- Company Secretary and Compliance Officer RPG LIFE SCIENCES LTD. - 532983 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith intimation of loss of share certificate as received by us from Link Intime Private Limited, our Registrar and Share Transfer Agent, being submitted to you pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record.